New genetic models for C5a receptors

C5a 受体的新遗传模型

基本信息

  • 批准号:
    10433917
  • 负责人:
  • 金额:
    $ 41.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Abstract The complement system is not only an integral arm of innate immunity but also significantly contributes to the menacing severity of infection-associated inflammation. The life-threatening inflammatory syndrome of acute respiratory distress syndrome (ARDS) frequently arises from uncontrolled bacterial pneumonia imposing persistent public health burdens. These disorders involve activation of the complement system with excessive generation of the complement anaphylatoxin, C5a, and therapeutic disruption of these processes could provide protection from tissue-destructive inflammation. C5a ligates with its homologous receptors, C5aR1 and C5aR2, encoded by two adjacent genes. The functional roles of C5aR1 and C5aR2 across different tissues are not entirely clear, and the data for C5aR2 is controversial. In our preliminary work, we have generated a mouse strain with a ~12.6 kb deletion of both C5aRs (C5aR1/2-/- DKO) by CRISPR/Cas9 gene editing, another mouse strain for reporting and conditional deletion of C5aR2 (C5aR2LacZ; C5aR2flox) and we have access to conditional C5aR1 mice (C5aR1flox). These novel tools will facilitate the testing of our central hypothesis that a functional cooperation of C5aR1 on neutrophils with C5aR2 on type II alveolar epithelial cells determines the development and progression of lung injury and pneumococcal pneumonia. We will focus on three specific aims: (1) Based on our preliminary findings with bone marrow chimeric mice, the expression and functional relevance of C5aR2 in type II alveolar epithelial cells (AECIIs) will be studied including endpoints such as alveolar-capillary barrier disruption, signatures of cytokines/chemokines and epithelium-leukocyte cross-talk during lung injury and pneumococcal pneumonia. In addition, the presence of C5aR2 will be compared to C5aR1 in normal human lung tissues. (2) We will characterize the roles of C5aRs in Ly6G+ neutrophils during lung injury and pneumococcal pneumonia using mice with neutrophil-specific deletion of C5aR1 and C5aR2. To elucidate potential effects of C5aR1 on subsets of lung invading neutrophils and their maturation states, we will pursue single-cell RNA-Seq studies using a novel droplet-based high-throughput method. (3) We will investigate the functional synergisms, redundancies and diversities of C5aRs by comparing the inflammation phenotypes of C5aR1/2-/- DKO to C57BL/6 (Wt), C5aR1-/- and C5aR2-/- mice during lung injury and pneumococcal pneumonia. Neutrophils and AECIIs isolated from the aforementioned pneumonia experiments will be used for comparing the whole transcriptomes of these four mouse strains in deep sequencing studies (bulk RNA-Seq) focusing on elucidation the molecular pathways of neutrophil-AECIIs interactions and a search for novel C5aR1/2-regulated genes. These investigations will aim to advance the current concepts and resolve ongoing controversies regarding the functional antagonism or operational synergism of the C5aRs. In future, these insights may be helpful for advancing concepts for therapeutic interventions in inflammatory diseases
摘要 补体系统不仅是先天免疫的重要组成部分,而且对机体的免疫功能具有重要作用。 严重的感染相关炎症。危及生命的急性炎症性综合征 呼吸窘迫综合征(ARDS)常由不受控制的细菌肺炎引起 持续的公共卫生负担。这些疾病涉及补体系统的激活,过量的 补体过敏性毒素C5a的产生和这些过程的治疗中断可以提供 保护身体免受组织破坏性炎症。C5a与其同源受体C5aR1和C5aR2连接, 由两个相邻的基因编码的。C5aR1和C5aR2在不同组织中的功能作用不同 完全清楚,而C5aR2的数据是有争议的。在我们的初步工作中,我们已经产生了一只老鼠 CRISPR/Cas9基因编辑两个C5aRs(C5aR1/2-/-DKO)~12.6kb缺失的菌株,另一只小鼠 报告和条件删除C5aR2的菌株(C5aR2LacZ;C5aR2Flox),我们可以访问条件 C5aR1小鼠(C5aR1flx)。这些新的工具将有助于测试我们的中心假设,即功能 中性粒细胞上的C5aR1与II型肺泡上皮细胞上的C5aR2的协同作用决定了 肺损伤和肺炎球菌肺炎的发生和发展。我们将重点关注三个具体的问题 目的:(1)基于我们在骨髓嵌合小鼠中的初步发现,表达和功能 将研究C5aR2在II型肺泡上皮细胞(AECII)中的相关性,包括以下终点 肺泡-毛细血管屏障破坏、细胞因子/趋化因子特征和上皮-白细胞串扰 在肺损伤和肺炎球菌肺炎期间。此外,C5aR2的存在将与 正常人肺组织中的C5aR1。(2)我们将研究C5aRs在Ly6G+中性粒细胞中的作用。 使用中性粒细胞特异性C5aR1和C5aR2缺失的小鼠的肺损伤和肺炎球菌肺炎。 为了阐明C5aR1对肺侵袭性中性粒细胞亚群及其成熟状态的潜在影响,我们 将使用一种新的基于液滴的高通量方法进行单细胞RNA-SEQ研究。(3)我们会 通过比较炎症反应来研究C5aRs的功能协同作用、冗余和多样性 C5aR1/2-/-DKO对C57BL/6(Wt)、C5aR1-/-和C5aR2-/-小鼠肺损伤的表型 肺炎球菌肺炎。从上述肺炎实验中分离的中性粒细胞和AECII 将用于在深度测序研究中比较这四个小鼠品系的整个转录本 (Bulk RNA-Seq)侧重于阐明中性粒细胞-AECIIs相互作用的分子途径和搜索 对于C5aR1/2调节的新基因。这些调查的目的将是推进当前的概念和解决 关于C5AR的功能拮抗或业务协同作用的持续争议。在未来, 这些见解可能有助于推进炎症性疾病治疗干预的概念

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A single-cell lung atlas of complement genes identifies the mesothelium and epithelium as prominent sources of extrahepatic complement proteins.
  • DOI:
    10.1038/s41385-022-00534-7
  • 发表时间:
    2022-05
  • 期刊:
  • 影响因子:
    8
  • 作者:
    Chaudhary, Neha;Jayaraman, Archana;Reinhardt, Christoph;Campbell, Joshua D.;Bosmann, Markus
  • 通讯作者:
    Bosmann, Markus
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Markus Bosmann其他文献

Markus Bosmann的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Markus Bosmann', 18)}}的其他基金

Interleukin-27 in host response to Legionella infection
Interleukin-27 在宿主对军团菌感染的反应中
  • 批准号:
    10745091
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
Bacterial polyphosphates in sepsis
败血症中的细菌多磷酸盐
  • 批准号:
    10357962
  • 财政年份:
    2021
  • 资助金额:
    $ 41.25万
  • 项目类别:
Bacterial polyphosphates in sepsis
败血症中的细菌多磷酸盐
  • 批准号:
    10210680
  • 财政年份:
    2021
  • 资助金额:
    $ 41.25万
  • 项目类别:
Bacterial polyphosphates in sepsis
败血症中的细菌多磷酸盐
  • 批准号:
    10573217
  • 财政年份:
    2021
  • 资助金额:
    $ 41.25万
  • 项目类别:
Role reversal of MAVS in bacterial sepsis
MAVS 在细菌性脓毒症中的作用逆转
  • 批准号:
    10439602
  • 财政年份:
    2018
  • 资助金额:
    $ 41.25万
  • 项目类别:
Role reversal of MAVS in bacterial sepsis
MAVS 在细菌性脓毒症中的作用逆转
  • 批准号:
    9759979
  • 财政年份:
    2018
  • 资助金额:
    $ 41.25万
  • 项目类别:
New genetic models for C5a receptors
C5a 受体的新遗传模型
  • 批准号:
    10201727
  • 财政年份:
    2018
  • 资助金额:
    $ 41.25万
  • 项目类别:
Role reversal of MAVS in bacterial sepsis
MAVS 在细菌性脓毒症中的作用逆转
  • 批准号:
    10191010
  • 财政年份:
    2018
  • 资助金额:
    $ 41.25万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了